What is the management of postpartum hemorrhage (PPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Postpartum Hemorrhage (PPH)

Early administration of intravenous tranexamic acid (within 3 hours of birth) is strongly recommended in addition to standard care for women with clinically diagnosed postpartum hemorrhage following vaginal birth or cesarean section. 1

Definition and Diagnosis

Postpartum hemorrhage is defined as:

  • Blood loss ≥500 mL after delivery (any route)
  • Severe PPH: blood loss ≥1000 mL after delivery (any route)
  • Or any blood loss sufficient to compromise hemodynamic stability 1, 2

Prevention of PPH

First-line Preventive Measures

  • Administer prophylactic uterotonic agents immediately after delivery of the baby 2
  • Oxytocin is the first-line prophylactic drug (Grade A) 2:
    • 5-10 IU slow IV or IM at the time of shoulder release or immediately postpartum 1, 3
    • Can be administered either IV or IM (IV route may be more effective) 4

Additional Preventive Measures

  • After vaginal delivery:
    • Routine cord drainage, controlled cord traction, uterine massage, and routine bladder voiding are not systematically recommended 2
  • After cesarean delivery:
    • Placental delivery by controlled cord traction is recommended 2

Management Algorithm for PPH

1. Immediate Response (First 30 minutes)

  • Recognize PPH and call for help
  • Assess vital signs and blood loss (consider using a collection bag) 2
  • Manual uterine examination with antibiotic prophylaxis 2
  • Careful visual assessment of the lower genital tract 2
  • Uterine massage 2
  • Administer oxytocin 5-10 IU slow IV or IM, followed by maintenance infusion (not exceeding cumulative dose of 40 IU) 2
  • Start fluid resuscitation if bleeding persists or signs of clinical severity 2
  • Administer oxygen in cases of severe PPH 2

2. If Bleeding Continues (30-60 minutes)

  • Administer second-line uterotonics if oxytocin fails to control bleeding within 30 minutes:
    • Sulprostone (prostaglandin E2 analog) 2
    • Carboprost tromethamine (15-methyl prostaglandin F2α) 250 μg IM, may repeat at 15-90 minute intervals (maximum 8 doses) 5
    • Methylergonovine 0.2 mg IM (contraindicated in hypertensive patients) 6
  • Tranexamic acid 1 g IV (given over 10 minutes), with a second dose of 1 g IV if bleeding continues after 30 minutes or restarts within 24 hours 1
    • Must be given within 3 hours of birth for effectiveness 1
    • Benefit decreases by 10% for every 15-minute delay 1

3. If Bleeding Still Persists (>60 minutes)

  • Intrauterine balloon tamponade if pharmacological measures fail 2
  • Blood product administration:
    • Maintain hemoglobin >8 g/dL 2
    • Maintain fibrinogen level ≥2 g/L 2
    • RBC, fibrinogen, and fresh frozen plasma may be administered without awaiting laboratory results in severe cases 2
  • Prevent and treat hypothermia by warming infusion solutions and blood products 2

4. Invasive Interventions (if medical management fails)

  • Arterial embolization or surgical intervention 2
  • No specific conservative surgical technique is favored over others 2
  • Hospital-to-hospital transfer for embolization is possible if hemoperitoneum is ruled out and patient is hemodynamically stable 2

Approach Based on Cause of PPH (Four T's)

  1. Tone (Uterine Atony) - most common cause (>75% of cases) 1

    • Uterine massage
    • Uterotonics (oxytocin, prostaglandins, ergot alkaloids)
    • Intrauterine balloon tamponade
  2. Trauma

    • Repair of lacerations
    • Drainage of hematomas
    • Correction of uterine inversion
    • Repair of uterine rupture
  3. Tissue

    • Manual removal of retained placenta or placental fragments
    • Surgical evacuation if necessary
  4. Thrombin (Coagulopathy)

    • Blood product replacement
    • Treatment of underlying cause (amniotic fluid embolism, placental abruption, HELLP syndrome)

Important Considerations

  • Tranexamic acid is most effective when given early (within 3 hours of birth) and should not be given after this time frame 1
  • Massive transfusion protocols should be activated for blood loss exceeding 1,500 mL 7
  • Rapid team-based care is essential to minimize morbidity and mortality 7
  • CT imaging may be considered in hemodynamically stable patients when conventional medical treatment has been unsuccessful, particularly for suspected intra-abdominal hemorrhage or postsurgical complications 1

Pitfalls to Avoid

  • Delaying tranexamic acid administration beyond 3 hours after birth (may be potentially harmful) 1
  • Failing to recognize and treat PPH promptly
  • Not escalating to second-line treatments within 30 minutes if first-line treatment fails
  • Overlooking non-atonic causes of PPH (trauma, retained tissue, coagulopathy)
  • Inadequate fluid resuscitation and blood product replacement

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.